Patient characteristics
| Characteristic . | Value . |
|---|---|
| Sex, no. (%) | |
| Female | 77 (44) |
| Male | 98 (56) |
| Age at diagnosis | |
| Median, y | 69.9 |
| Range, y | 29.5-92.3 |
| Younger than 70 y, no. (%) | 92 (53) |
| 70 y or older, no. (%) | 83 (47) |
| Overall survival | |
| Median overall survival, y | 7.0 |
| No. of deaths (%) | 110 (63) |
| Censored events, no. (%) | 65 (37) |
| Median follow-up time, y | 6.4 |
| Range, y | 0.01-14.9 |
| Time to treatment | |
| Median time to first treatment, y | 2.3 |
| No. treated (%) | 107 (61) |
| Censored events, no. (%) | 68 (39) |
| Clinical stage, no. (%) | |
| Binet A | 115 (66) |
| Binet B | 33 (19) |
| Binet C | 27 (15) |
| Characteristic . | Value . |
|---|---|
| Sex, no. (%) | |
| Female | 77 (44) |
| Male | 98 (56) |
| Age at diagnosis | |
| Median, y | 69.9 |
| Range, y | 29.5-92.3 |
| Younger than 70 y, no. (%) | 92 (53) |
| 70 y or older, no. (%) | 83 (47) |
| Overall survival | |
| Median overall survival, y | 7.0 |
| No. of deaths (%) | 110 (63) |
| Censored events, no. (%) | 65 (37) |
| Median follow-up time, y | 6.4 |
| Range, y | 0.01-14.9 |
| Time to treatment | |
| Median time to first treatment, y | 2.3 |
| No. treated (%) | 107 (61) |
| Censored events, no. (%) | 68 (39) |
| Clinical stage, no. (%) | |
| Binet A | 115 (66) |
| Binet B | 33 (19) |
| Binet C | 27 (15) |